assess AI software compliance GxP Archives

08/10/2026

Artificial intelligence (AI) is becoming increasingly important in pharmaceutical operations, from data analysis and quality management to research, manufacturing, and regulatory processes. However, using AI software in a regulated GxP environment can introduce new compliance, validation, data integrity, and governance challenges.

Understanding AI software compliance risks is important before an AI application is implemented or relied upon for GxP-related activities. Pharmaceutical companies should regularly assess these risks through structured AI compliance audits to ensure that systems remain controlled, reliable, and aligned with applicable regulatory expectations.

What Are AI Software Compliance Risks in Pharma?

AI software compliance risks are potential issues that can affect the reliability, security, validation, data integrity, or regulatory compliance of an AI system used within pharmaceutical or other regulated environments.

Unlike traditional software, AI systems may learn from data, produce variable outputs, or change as models and datasets are updated. This creates additional considerations for validation, change control, human oversight, vendor management, and ongoing monitoring.

Below are some of the key AI software compliance risks that pharmaceutical companies should consider during an audit.

1. Non-Deterministic AI Behavior

One of the major AI audit risks in pharma is non-deterministic behavior. Some AI systems may generate different outputs when presented with the same or similar inputs. This can make traditional software validation approaches more challenging.

Auditors should evaluate:

How variability in AI outputs is addressed during validation
Whether appropriate acceptance criteria have been established
How model performance is monitored over time
Whether unexpected outputs are documented and investigated
How the organization determines whether AI output is suitable for its intended use

A risk-based validation strategy can help organizations establish appropriate controls for AI applications.

2. Data Integrity Risks

AI systems depend heavily on data. Poor-quality, incomplete, inaccurate, or improperly controlled data can affect model performance and potentially result in unreliable outputs.

Data integrity should therefore be a major area of focus during an AI compliance audit.

Auditors should assess:

Whether training data is appropriately controlled
How data quality is evaluated and maintained
Whether access controls protect critical data
Whether relevant audit trails are available
How AI inputs and outputs are recorded
Whether data changes are traceable
How data integrity principles are incorporated into AI governance

Organizations should ensure that data used by AI systems remains accurate, complete, consistent, and traceable throughout its lifecycle.

3. Model Governance and Change Control

AI models can change because of software updates, new training data, configuration changes, or modifications to algorithms. Without appropriate governance, these changes may affect the validated state of an AI application.

An AI audit should determine whether the organization has:

A documented AI governance framework
Defined model ownership and responsibilities
Formal change control procedures
Risk assessments for model changes
Procedures for evaluating model updates
Appropriate revalidation or verification requirements
Documentation showing approval of significant changes

Strong model governance helps pharmaceutical companies maintain control over AI software throughout its operational lifecycle.

4. Lack of AI Model Transparency

Some AI technologies can function as complex systems where it is difficult to understand exactly how a particular output was generated. This lack of transparency can create challenges for regulated organizations.

During an audit, companies should review whether:

The AI model and intended use are adequately documented
Model assumptions and limitations are clearly defined
Known risks and performance limitations are recorded
AI outputs can be appropriately reviewed
Relevant decisions and supporting information are documented
Users understand when AI recommendations require additional assessment

Transparency becomes particularly important when AI output contributes to quality, safety, manufacturing, or other regulated decisions.

5. Insufficient Human Oversight

AI should not automatically replace qualified human judgment in regulated pharmaceutical processes. Depending on the intended use and risk level, human review may be necessary before AI-generated recommendations are accepted or acted upon.

An AI audit for pharma companies should examine:

Whether human review requirements are clearly defined
Who is responsible for reviewing AI-generated outputs
Whether qualified personnel can reject or override AI recommendations
How human interventions are documented
Whether employees are trained to recognize AI limitations
How critical AI-supported decisions are escalated

Clear accountability helps ensure that responsibility remains with appropriately qualified personnel.

6. AI Vendor and Supplier Risks

Pharmaceutical companies often rely on third-party providers for AI platforms, models, cloud infrastructure, or software components. This creates additional supplier and compliance risks.

An AI compliance audit should assess:

Whether the AI vendor has been appropriately qualified
Whether supplier risk has been assessed
Whether quality agreements are established where required
What validation and technical documentation the vendor provides
How vendor changes are communicated
Whether service continuity and contingency plans are available
How outsourced AI activities are monitored

Third-party AI applications should be managed according to their potential impact on product quality, patient safety, data integrity, and regulatory compliance.

7. Evolving Regulatory Requirements

AI regulations and regulatory expectations continue to develop globally. Pharmaceutical organizations must therefore monitor changes that could affect AI applications used within GxP processes.

Organizations should evaluate:

How regulatory developments are monitored
Who is responsible for maintaining AI compliance
Whether internal policies are updated when requirements change
How new regulatory expectations are assessed
Whether AI risk assessments are periodically reviewed
How compliance evidence is maintained

A proactive approach can help organizations identify emerging GxP AI risks before they become significant compliance problems.

8. Inadequate AI Risk Assessment

Another important AI software risk is failing to properly assess the intended use and potential impact of an AI application before implementation.

A comprehensive risk assessment should consider:

Intended use of the AI system
GxP impact
Data criticality
Patient or product impact
Model complexity
Human involvement
Failure scenarios
Cybersecurity and access risks
Vendor dependencies
Monitoring and performance requirements

Risk assessment should also be revisited when the AI application, process, data, or intended use changes.

9. Weak Documentation and Validation Evidence

AI applications used in regulated environments require appropriate documentation to demonstrate that the system is suitable for its intended purpose.

Auditors should review whether organizations maintain appropriate evidence covering:

Intended use and system requirements
Risk assessments
Model specifications
Data sources and controls
Validation or verification activities
Test results
Change history
Monitoring activities
Deviations and investigations
Periodic reviews

Insufficient documentation can make it difficult to demonstrate control during an inspection or regulatory audit.

10. Inadequate Ongoing Monitoring

AI compliance does not end after implementation or initial validation. Model performance can change over time because of new data, environmental changes, software updates, or changes in usage.

Companies should establish appropriate monitoring processes to identify:

Unexpected model behavior
Performance degradation
Data quality issues
Significant changes in outputs
Unauthorized changes
New compliance risks
Model drift where applicable

Regular monitoring allows organizations to identify and address AI compliance risks before they affect regulated operations.

How GxP Cellators Helps With AI Software Compliance Risks

GxP Cellators provides specialized AI compliance auditing and GxP audit support to help pharmaceutical and life sciences organizations identify, assess, and manage risks associated with AI applications.

Its AI-focused audit services can include:

AI compliance risk assessments
AI governance framework audits
Training data quality and integrity assessments
AI model validation documentation reviews
Human oversight and accountability audits
AI vendor and supplier audits
Regulatory compliance assessments
AI software compliance reviews
Mock AI audits and inspection-readiness assessments
Gap assessments for AI applications used in GxP environments

GxP Cellators takes a risk-based approach that considers the intended use, GxP impact, data criticality, system complexity, and regulatory requirements associated with each AI application.

Why Audit AI Software Compliance Risks?

A structured AI compliance audit can help pharmaceutical companies:

Identify compliance gaps early
Strengthen AI governance
Improve data integrity controls
Support appropriate validation activities
Establish effective human oversight
Improve vendor and supplier controls
Maintain better documentation
Prepare for regulatory inspections
Reduce operational and compliance risks

As AI adoption increases across pharmaceutical operations, organizations should treat AI governance and compliance as an ongoing responsibility rather than a one-time implementation activity.

Frequently Asked Questions

What are the top AI software compliance risks in pharma?

The major risks include non-deterministic AI behavior, data integrity issues, inadequate model governance, insufficient transparency, weak human oversight, vendor management gaps, documentation problems, inadequate validation, and evolving regulatory requirements.

How can pharmaceutical companies manage AI compliance risks?

Companies can manage AI compliance risks through risk-based assessments, appropriate validation, data integrity controls, model governance, change control, human oversight, vendor qualification, documentation, ongoing monitoring, and regular compliance audits.

Why is data integrity important for AI software?

AI models depend on reliable data. Poor-quality or improperly controlled data can result in inaccurate or unreliable outputs. Strong data integrity controls help ensure that AI systems use trustworthy and traceable information.

Should AI software be audited after implementation?

Yes. AI systems should be monitored and reviewed throughout their lifecycle. Changes in models, data, software, intended use, or regulatory expectations may introduce new risks that require reassessment.

How can GxP Cellators help with AI compliance auditing?

GxP Cellators can support organizations through AI compliance risk assessments, AI governance audits, data integrity reviews, model validation documentation assessments, human oversight audits, vendor assessments, regulatory compliance reviews, and AI-focused gap assessments.

Conclusion

AI can provide significant benefits to pharmaceutical companies, but its use in regulated environments requires appropriate governance and oversight. AI software compliance risks can affect data integrity, validation, model performance, documentation, supplier management, and regulatory compliance.

Regular AI compliance auditing helps organizations identify weaknesses, establish appropriate controls, and maintain confidence in AI applications used within GxP processes. A risk-based and lifecycle-focused approach can help pharmaceutical companies adopt AI while maintaining quality and compliance.

If your organization is implementing or already using AI software in a GxP environment, GxP Cellators can help assess your AI compliance risks and identify practical areas for improvement.

Contact GxP Cellators: /contact/

by Vinod

08/10/2026

Artificial intelligence is becoming increasingly common across pharmaceutical, biotechnology, clinical research, laboratory, and other regulated environments. From data analysis and quality processes to manufacturing and safety activities, AI software can support important GxP operations.

However, using AI in a regulated environment requires more than checking whether the software works as expected. Organizations must determine whether the system is appropriately controlled, documented, validated, secure, and suitable for its intended GxP use.

Knowing how to assess AI software compliance in a GxP environment helps organizations identify potential risks before they affect product quality, patient safety, data integrity, or regulatory compliance.

What Is AI Software Compliance in a GxP Environment?

AI software compliance refers to the process of evaluating whether an AI-enabled application meets applicable GxP requirements and organizational quality standards.

Unlike conventional computerized systems, AI applications can involve machine learning models, changing datasets, probabilistic outputs, model updates, and complex decision-making processes. Therefore, an AI software assessment should consider both traditional computerized system controls and AI-specific risks.

The assessment may cover:

Intended use and GxP impact
AI and machine learning functionality
Data quality and integrity
Model development and validation
Human oversight
System security and access controls
Audit trails
Change management
Documentation and governance
Regulatory requirements

Also read: AI Software Compliance Audits in Pharma: Complete 2026 Guide

Step 1: Understand the AI Software and Its Intended Use

The first step to assess AI software compliance in GxP is to understand exactly what the application does and how it is used.

Start by documenting:

What is the intended use of the AI software?
Which GxP process does it support?
Does it influence product quality, patient safety, or regulatory decisions?
What type of AI or machine learning technology is used?
What data is used to train or operate the model?
How are AI outputs generated?
Can the model or algorithm change over time?
What level of human review is required?

The risk of an AI application depends heavily on its intended use. An AI tool supporting a low-risk administrative activity may require different controls from an AI system influencing laboratory results, manufacturing decisions, clinical processes, or pharmacovigilance activities.

Step 2: Identify Applicable GxP Regulations and Standards

The next stage of an AI software compliance assessment is determining which regulations, standards, and guidance apply to the system.

Depending on the application and its intended use, the assessment may consider:

21 CFR Part 11 for electronic records and electronic signatures
EU GMP Annex 11 for computerized systems
GAMP 5 principles for risk-based computerized system validation
ALCOA+ principles for data integrity
Applicable FDA expectations
EMA requirements and guidance
Health Canada requirements
MHRA expectations
WHO guidance where applicable

Not every requirement will apply to every AI application. A risk-based assessment should determine which requirements are relevant based on the system’s functionality, GxP impact, data, and intended use.

Step 3: Review AI Software Documentation

Documentation provides evidence of how the AI software was designed, developed, tested, implemented, and maintained.

During an AI compliance review, organizations should evaluate relevant documentation such as:

User requirements and system requirements
Functional and technical specifications
Validation plans and reports
AI model development documentation
Model training and testing information
Training data documentation
Data sources and data-quality records
Risk assessments
Standard operating procedures
Change-control records
System security documentation
User manuals
Training records

Documentation should provide sufficient evidence that the AI software is controlled throughout its lifecycle.

Step 4: Assess AI-Specific and GxP Controls

After reviewing documentation, evaluate whether the controls implemented around the AI system are appropriate and effective.

Important areas include:

Data Integrity Controls

Assess whether AI inputs, processing activities, outputs, and relevant records maintain data integrity throughout the system lifecycle.

Controls should support principles such as attribution, legibility, contemporaneous recording, originality, accuracy, completeness, consistency, and availability.

Audit Trails

Determine whether important AI-related activities are appropriately recorded. This may include changes to inputs, outputs, configurations, user activities, and model versions.

Access Controls

Review whether only authorized users can access, modify, configure, or manage the AI application and its associated data.

Model Change Control

AI models may be updated because of changes in algorithms, training data, parameters, or system configuration. Changes should be appropriately assessed, documented, tested, approved, and controlled.

Human Oversight

AI outputs should be reviewed according to the risk associated with the intended use. Organizations should define when human intervention, review, approval, or escalation is required.

Security Controls

Evaluate cybersecurity, user authentication, authorization, data protection, and other security measures relevant to the AI system.

Step 5: Identify Compliance Gaps

The AI software assessment should compare the current state of the system against applicable GxP requirements and internal quality expectations.

Common gaps may include:

Incomplete system documentation
Insufficient AI governance
Weak data controls
Inadequate model validation
Missing or incomplete audit trails
Poor change-control processes
Unclear human oversight responsibilities
Insufficient user training
Inadequate risk assessments
Regulatory compliance gaps

Each finding should be evaluated according to its potential impact on product quality, patient safety, data integrity, and regulatory compliance.

Step 6: Develop a Risk-Based Remediation Plan

Identifying gaps is only one part of an effective AI compliance review. Organizations should also establish a practical remediation strategy.

A remediation plan should:

Prioritize findings according to risk.
Assign ownership for each corrective action.
Establish realistic completion timelines.
Define required corrective and preventive actions.
Update procedures and documentation where necessary.
Implement and test required controls.
Verify the effectiveness of completed actions.

A risk-based approach helps organizations focus resources on the AI software issues that could have the greatest GxP impact.

Common Challenges When Assessing AI Software Compliance

AI applications can create compliance challenges that are not always present in traditional computerized systems.

Changing Models

Machine learning models may change as algorithms, parameters, or training datasets are updated. Organizations therefore need appropriate lifecycle and change-control processes.

Complex Data Sources

AI applications may use large or diverse datasets. Organizations must understand where data comes from and how its quality, integrity, and suitability are maintained.

Explainability and Human Oversight

Some AI systems can produce complex outputs that are difficult to interpret. Defining appropriate human review and decision-making responsibilities is therefore important.

AI Governance

Organizations should establish clear ownership, accountability, risk management, monitoring, and lifecycle controls for AI applications used in GxP processes.

How GxP Cellators Supports AI Software Compliance Assessments

GxP Cellators provides AI software compliance assessment and GxP auditing support for organizations using AI technologies in regulated environments.

Our approach helps organizations evaluate their AI applications, identify compliance risks, review controls, and develop practical remediation strategies.

Our AI software compliance assessment services can include:

AI software compliance assessments
GxP AI gap assessments
Regulatory requirement reviews
Documentation assessments
AI control assessments
Data integrity assessments
Risk assessments
AI governance reviews
Validation and lifecycle assessments
Remediation planning
Mock audit support

The assessment approach can be tailored according to the AI application’s intended use, GxP impact, technology, and regulatory requirements.

Why Choose GxP Cellators?

Assessing AI in a regulated environment requires knowledge of both GxP compliance and AI technologies. GxP Cellators combines these areas to provide practical compliance support.

Organizations can benefit from:

GxP and AI compliance expertise
Risk-based assessment methodologies
Regulatory-focused reviews
Practical and actionable recommendations
Support for data integrity and computerized system controls
Confidential handling of proprietary information
Remediation-focused compliance guidance

Frequently Asked Questions

What is the first step to assess AI software compliance in GxP?

The first step is to understand the AI application’s intended use, GxP impact, functionality, data, model characteristics, and level of human oversight. This information helps determine the appropriate compliance and risk assessment approach.

What regulations may apply to AI software used in GxP environments?

Depending on the system and intended use, requirements may include 21 CFR Part 11, EU GMP Annex 11, GAMP 5 principles, data integrity expectations, and applicable FDA, EMA, Health Canada, MHRA, or WHO guidance.

What are common AI software compliance gaps?

Common gaps can include incomplete documentation, inadequate model validation, weak data integrity controls, insufficient change control, unclear human oversight, missing governance processes, and inadequate risk assessments.

Why is human oversight important for GxP AI software?

Human oversight helps ensure that AI outputs are appropriately reviewed and that important GxP decisions are not made without suitable controls. The level of oversight should be based on the system’s risk and intended use.

Can GxP Cellators help identify AI software compliance gaps?

Yes. GxP Cellators can support organizations through AI software compliance assessments, documentation reviews, gap assessments, control evaluations, data integrity reviews, and remediation planning.

Also read: AI Validation vs Traditional CSV: What GxP Auditors Need to Know

Assess Your AI Software Compliance with GxP Cellators

AI can provide significant benefits to regulated organizations, but its use must be supported by appropriate controls, documentation, validation, governance, and human oversight.

A structured AI software compliance assessment can help identify weaknesses before they become significant GxP risks. By evaluating the system from both AI and regulatory perspectives, organizations can build a more controlled and inspection-ready environment.

If you need support to assess AI software compliance in a GxP environment, contact GxP Cellators to discuss your requirements.

Contact GxP Cellators: /contact/

by Vinod

08/10/2026

Artificial intelligence (AI) and machine learning are becoming increasingly important across pharmaceutical research, manufacturing, quality, clinical, and regulatory processes. However, using AI in a regulated environment creates new compliance considerations around data, software validation, model performance, human oversight, security, and change management.

A structured AI software audit checklist helps pharmaceutical companies evaluate whether an AI application is suitable for its intended use and whether appropriate controls are in place throughout its lifecycle.

For GxP environments, an AI audit should go beyond checking whether the software works. Auditors should also examine how the system was developed, validated, monitored, changed, documented, and controlled.

Also read: AI Software Compliance Audits in Pharma: Complete 2026 Guide

What Is an AI Software Audit?

An AI software audit is a systematic review of an artificial intelligence or machine learning application to determine whether it meets defined quality, compliance, security, and performance expectations.

In pharmaceutical environments, the audit may consider:

Intended use and context of use
GxP impact and risk classification
Data governance and data integrity
AI model development and validation
Software lifecycle controls
Human oversight
Audit trails and access controls
Cybersecurity
Change management
Vendor controls
Regulatory and quality requirements

FDA’s current risk-based software assurance guidance specifically includes artificial intelligence and machine learning tools among technologies that can be considered within a risk-based assurance framework when used in production or quality management systems.

AI Software Audit Checklist for Pharmaceutical Companies

The following checklist can help auditors and pharmaceutical organizations review important areas of an AI application.

1. AI System Inventory and Risk Assessment

The first step is identifying all AI and machine learning applications used within the organization.

Check whether:

All AI systems are listed in an approved inventory.
The intended use of each AI application is documented.
The context of use is clearly defined.
Each system has undergone a documented risk assessment.
GxP impact has been evaluated.
Critical or high-risk applications receive appropriate controls.
System ownership and accountability are clearly assigned.
Risk assessments are periodically reviewed and updated.

A risk-based approach is particularly important because not every AI application has the same impact on product quality, patient safety, data integrity, or regulatory decisions.

2. AI Governance and Oversight

Effective AI governance establishes who is responsible for approving, monitoring, and controlling AI systems.

An audit should determine whether:

A documented AI governance framework exists.
Roles and responsibilities are defined.
AI system owners have been assigned.
Quality and regulatory functions are involved where required.
AI use is subject to appropriate approval procedures.
Model changes are controlled.
AI performance is periodically reviewed.
Escalation procedures exist for unexpected results.
Governance requirements are applied throughout the AI lifecycle.

FDA and EMA’s joint principles for good AI practice in drug development emphasize human-centric design, risk-based approaches, clear context of use, multidisciplinary expertise, data governance, model development, performance assessment, and lifecycle management.

3. Training Data Quality and Governance

AI performance depends heavily on the quality and suitability of its data.

The AI software audit checklist should therefore examine:

Whether training data comes from reliable sources.
Whether data is appropriate for the intended use.
Whether data sources are documented.
Whether data completeness has been evaluated.
Whether preprocessing activities are documented.
Whether data quality checks are performed.
Whether potential bias has been assessed.
Whether data changes are controlled.
Whether data lineage can be demonstrated.
Whether data retention requirements are defined.

For GxP systems, organizations should also consider whether data remains attributable, legible, contemporaneous, original, and accurate. EMA identifies ALCOA principles as a key part of pharmaceutical data integrity expectations.

4. AI Model Development and Validation

AI models should be developed and evaluated using a controlled and documented process.

Auditors should check:

Whether model requirements are documented.
Whether the development methodology is defined.
Whether acceptance criteria are established.
Whether appropriate performance metrics are selected.
Whether independent test data is used.
Whether validation activities are documented.
Whether model limitations are identified.
Whether expected performance ranges are established.
Whether model performance is monitored after deployment.
Whether deviations from expected performance are investigated.

The depth of assurance should reflect the AI application’s intended use and risk.

5. AI Model Documentation

Complete documentation is essential for demonstrating that an AI system is controlled and suitable for its intended purpose.

Review whether documentation includes:

Intended use and context of use
Model architecture
Input and output specifications
Training data information
Data preprocessing methods
Model assumptions
Known limitations
Performance criteria
Validation results
Version history
Change history
Approval records
Monitoring requirements

Clear documentation also helps auditors understand how an AI system reaches or supports a particular outcome.

6. Human Oversight and Intervention

AI should not automatically replace appropriate human responsibility in regulated processes.

An audit should assess whether:

Human review of AI outputs is defined.
Personnel understand when intervention is required.
Users can override AI recommendations where appropriate.
Human interventions are documented.
Escalation procedures are established.
AI limitations are communicated to users.
Personnel receive appropriate training.
Critical decisions have suitable human oversight.

Human-centric design is one of the principles highlighted by FDA and EMA for responsible AI use in drug development.

7. Data Integrity and Audit Trails

Data integrity is a critical part of an AI audit pharma assessment because AI applications may process large volumes of data and generate outputs that influence regulated activities.

Auditors should verify:

Audit trails are enabled where required.
User access is controlled.
AI inputs and outputs can be traced.
Data changes are recorded.
Model changes are documented.
Critical records are protected from unauthorized modification.
Electronic records are appropriately controlled.
Data remains accurate and reliable throughout its lifecycle.

FDA’s GMP guidance also emphasizes validation and controls over computerized systems, including controls against unauthorized access or data changes.

8. AI Software Security

Security risks should be included in the pharmaceutical AI audit.

The review may cover:

User authentication
Role-based access
Privileged access management
Data encryption
Secure interfaces
Protection against unauthorized model changes
Protection against malicious inputs
Data poisoning risks
Model theft risks
Security monitoring
Incident response
Security documentation

Security controls should be appropriate to the AI application’s risk, data sensitivity, and intended use.

9. Regulatory and GxP Compliance

AI systems used in regulated processes should be evaluated against applicable regulatory and quality requirements.

Depending on the system and its intended use, an audit may review:

GxP requirements
Data integrity expectations
Computerized system validation or assurance
21 CFR Part 11 where applicable
EU GMP Annex 11 where applicable
Internal quality procedures
Electronic record controls
Change control
Deviation management
CAPA requirements
Applicable FDA and EMA expectations

Importantly, regulatory requirements should be assessed according to the actual intended use of the AI system rather than assuming that every AI application requires the same level of validation.

FDA’s 2026 Computer Software Assurance guidance supports a risk-based approach to determining appropriate assurance activities and specifically recognizes AI/ML tools within its examples.

10. AI Vendor and Supplier Management

Many pharmaceutical organizations use third-party AI platforms, cloud services, models, or software providers. These suppliers should therefore be included in the audit strategy.

Check whether:

The AI vendor has been appropriately qualified.
Supplier risk has been assessed.
A quality agreement exists where required.
Vendor responsibilities are documented.
Validation or assurance documentation is available.
Software updates are communicated.
AI model changes are controlled.
Vendor performance is periodically reviewed.
Supplier audits are performed when justified by risk.
Business continuity and contingency plans exist.

Third-party AI should not be treated as outside the organization’s quality responsibility simply because the underlying technology is supplied by another company.

11. AI Change Management and Lifecycle Control

AI systems can change over time because of software updates, model retraining, new datasets, configuration changes, or modifications to algorithms.

An audit should therefore verify:

AI changes are formally documented.
Change requests are risk assessed.
Model updates are reviewed before implementation.
Validation or testing is performed when required.
Approval is documented.
Previous versions can be identified.
Retraining activities are controlled.
Post-change performance is evaluated.
Unexpected changes are investigated.

Lifecycle management is an important part of current AI governance principles, particularly where AI systems may evolve after initial implementation.

12. AI Performance Monitoring

An AI system should continue to perform as expected after deployment.

Organizations should define appropriate monitoring for:

Accuracy
Reliability
Model performance
Data quality
Unexpected outputs
Drift
Bias
Error rates
User feedback
Critical incidents
Performance against acceptance criteria

Where an AI system is used for a regulated activity, predefined actions should exist for performance deterioration or unexpected behavior.

Common Findings During AI Software Audits

Some common findings may include:

Incomplete AI system inventories
Missing or unclear intended-use documentation
Weak AI governance
Poor training data documentation
Inadequate data lineage
Insufficient model validation
Missing model limitations
Weak change control
Inadequate human oversight
Poor audit trail controls
Incomplete vendor qualification
Insufficient cybersecurity controls
Lack of ongoing performance monitoring

Identifying these issues early can help organizations address compliance gaps before they become larger quality or regulatory concerns.

How to Prepare for an AI Software Audit

Pharmaceutical companies can improve audit readiness by taking a structured approach.

Before an audit:

Identify all AI applications.
Document intended use and context of use.
Complete a risk assessment.
Review data governance and integrity controls.
Verify validation and assurance documentation.
Review model development records.
Check change-control history.
Assess human oversight.
Review cybersecurity controls.
Evaluate AI vendors.
Review performance monitoring.
Track and close identified CAPA actions.

A pre-audit assessment can help identify missing documentation and control weaknesses before a formal audit or regulatory inspection.

How GxP Cellators Supports AI Software Audits

GxP Cellators provides AI software auditing services for pharmaceutical and other regulated organizations seeking to evaluate the compliance, quality, and control of AI applications.

Its AI audit support can include:

AI software compliance audits
Pre-audit readiness assessments
AI governance reviews
AI risk assessments
Training data quality reviews
Data integrity assessments
AI model validation documentation reviews
Human oversight assessments
AI cybersecurity assessments
Regulatory compliance reviews
Vendor and supplier audits
Mock audit support
CAPA review and follow-up

GxP Cellators applies a risk-based approach to help organizations identify practical gaps and develop actionable improvement plans.

Why Choose GxP Cellators for AI Software Auditing?

GxP Cellators combines GxP compliance knowledge with an understanding of emerging AI technologies to support organizations implementing AI in regulated environments.

The approach focuses on:

Risk-based audit planning
GxP and quality considerations
Data integrity
AI governance
Software assurance and validation
Regulatory expectations
Practical audit findings
Corrective and preventive actions
Confidential handling of client information

The objective is not simply to identify problems but to help organizations understand the compliance risk and prioritize appropriate corrective actions.

Frequently Asked Questions

What should be included in an AI software audit checklist?

An AI software audit checklist should cover system inventory, intended use, risk assessment, governance, data quality, model development, validation, documentation, human oversight, data integrity, cybersecurity, regulatory compliance, change management, performance monitoring, and vendor management.

How often should AI software audits be conducted?

There is no single audit frequency for every AI application. The appropriate frequency should be based on factors such as GxP impact, system criticality, risk, changes to the model or software, vendor risk, and previous audit findings. Higher-risk applications may require more frequent review.

Who should conduct an AI software audit?

AI software audits should be performed by professionals who understand both AI technologies and regulated environments. Auditors should have knowledge of GxP requirements, software validation or assurance, data integrity, risk management, and AI lifecycle controls.

What are common findings in AI software audits?

Common findings can include incomplete system inventories, unclear intended use, inadequate governance, weak training data documentation, insufficient model validation, missing change controls, inadequate human oversight, weak data integrity controls, and incomplete vendor management.

Is AI software validation required in pharmaceutical environments?

The appropriate level of validation or software assurance depends on the intended use and risk of the system. GMP-related computerized systems require appropriate controls and validation, with the depth and scope depending on factors such as application complexity and criticality.

How does GxP Cellators support AI software audits?

GxP Cellators provides AI software auditing services covering risk assessment, governance, data integrity, model documentation, validation review, human oversight, cybersecurity, regulatory compliance, vendor assessment, mock audits, and CAPA follow-up.

How can I contact GxP Cellators for AI software audit support?

Organizations looking for AI software audit support can contact GxP Cellators to discuss their AI application, intended use, GxP requirements, and audit objectives.

Also read: How to Prepare for an AI Application Validation Audit in GxP

Contact GxP Cellators

If your pharmaceutical organization is implementing AI or already using AI in a GxP environment, a structured audit can help identify compliance risks and strengthen controls.

Contact GxP Cellators for AI software auditing support and discuss your requirements with the team.

by Vinod

07/10/2026

Artificial intelligence is becoming an important part of the pharmaceutical industry. Companies are using AI applications for drug discovery, manufacturing, quality operations, pharmacovigilance, data analysis, and other GxP-related activities. These technologies can improve efficiency, but they also introduce new compliance responsibilities.

AI software used within regulated pharmaceutical environments must be appropriately controlled, validated, documented, and monitored. Organizations also need to address data integrity, cybersecurity, human oversight, change management, and vendor risks.

This guide explains the key aspects of AI software compliance audits in pharma for 2026 and how GxP Cellators can help organizations evaluate the compliance of their AI applications.

What Is AI Software Compliance?

AI software compliance refers to ensuring that artificial intelligence applications used in GxP-regulated activities satisfy relevant regulatory and quality requirements.

Important compliance areas include:

Computerized system validation under requirements such as 21 CFR Part 11 and EU GMP Annex 11
Data integrity and ALCOA+ principles
Change control and AI model version management
User access controls and audit trails
Documentation and electronic records
Human oversight and accountability
AI vendor and supplier qualification
Risk management and ongoing monitoring

A compliance audit helps determine whether these controls are properly implemented and whether the AI application remains suitable for its intended GxP use.

The AI Software Compliance Audit Process

Phase 1: Audit Planning

The first stage establishes the scope, objectives, and approach of the audit.

Typical activities include:

Defining the audit scope and objectives
Identifying AI applications that require assessment
Determining applicable regulations and standards
Reviewing existing policies and documentation
Preparing an audit plan and compliance checklist

Phase 2: Audit Execution

During execution, auditors evaluate the AI application and supporting processes against defined requirements.

Activities may include:

Conducting an opening meeting
Reviewing relevant documentation and records
Interviewing responsible personnel
Performing system walkthroughs
Testing controls and reviewing supporting evidence
Identifying and documenting compliance findings

Phase 3: Audit Reporting

After completing the assessment, findings are evaluated and formally reported.

This stage generally involves:

Classifying findings according to risk
Preparing the audit report
Conducting a closing or close-out meeting
Agreeing on corrective actions
Establishing CAPA implementation timelines

Phase 4: Follow-Up

An audit is not complete simply because the report has been issued. Follow-up activities help confirm that identified issues have been effectively addressed.

Follow-up may include:

Reviewing CAPA plans
Verifying corrective action implementation
Evaluating CAPA effectiveness
Confirming that findings have been adequately resolved
Formally closing audit observations

Key Areas of AI Software Compliance Audits

Audit Area	Key Questions
AI System Inventory	Have all AI applications been identified, documented, and risk assessed?
AI Governance	Is there a defined governance framework for AI use?
Training Data	Are training datasets properly controlled, documented, and governed?
Model Development	Is the AI model development process documented and appropriately validated?
Model Documentation	Are the model architecture, intended use, limitations, and assumptions documented?
Human Oversight	Are appropriate processes established for reviewing AI-generated outputs?
Data Integrity	Are access controls, audit trails, and data integrity controls effective?
Security	Is the AI application protected against relevant cybersecurity and system-specific risks?
Regulatory Compliance	Does the application meet applicable requirements such as 21 CFR Part 11 and EU GMP Annex 11?
Vendor Management	Have AI software providers and vendors been appropriately qualified and assessed?

How GxP Cellators Supports AI Software Compliance Audits

GxP Cellators provides specialized AI software compliance audit services for pharmaceutical and GxP-regulated organizations. Its audit approach considers both the regulatory expectations applicable to GxP systems and the specific risks associated with artificial intelligence technologies.

AI Software Compliance Audit Services Include:

Full-scope AI software compliance audits
Pre-audit readiness assessments
AI governance framework assessments
Training data quality and governance audits
AI model validation documentation reviews
Human oversight process assessments
Data integrity audits for AI applications
AI security assessments
Regulatory compliance reviews
Vendor and supplier audits for AI applications
Mock AI audits for inspection preparation
CAPA verification and follow-up audits

These assessments can help organizations identify compliance weaknesses before they become significant regulatory or operational concerns.

Why Choose GxP Cellators for AI Software Compliance Audits?

Organizations working with AI in regulated environments need auditors who understand both GxP compliance and AI technology. GxP Cellators provides an integrated approach to help businesses assess their AI applications against applicable quality and regulatory expectations.

Key benefits include:

Auditors experienced in GxP requirements and AI technologies
Coverage of FDA, EMA, Health Canada, MHRA, and WHO expectations
Risk-based audit approaches tailored to individual AI applications
Practical and actionable audit reports
Support for identifying and remediating compliance gaps
Confidential handling of proprietary systems and information

Frequently Asked Questions

Q1: What is AI software compliance in pharma?

AI software compliance in pharma means ensuring that artificial intelligence applications used in GxP activities meet applicable requirements for validation, data integrity, documentation, human oversight, security, and vendor management.

Q2: Which regulations apply to AI software in pharma?

Depending on the intended use and jurisdiction, relevant requirements may include 21 CFR Part 11 for electronic records and signatures and EU GMP Annex 11 for computerized systems. Data integrity expectations based on ALCOA+ principles are also important. GAMP 5 can provide a risk-based framework for computerized system validation.

Q3: How often should AI software compliance audits be conducted?

Audit frequency should be determined according to the risk associated with the AI application. High-risk AI systems may require more frequent assessments, potentially annually, while lower-risk applications may follow longer audit intervals. Significant system changes, incidents, or regulatory developments can also trigger an audit.

Q4: What are common findings in AI software compliance audits?

Common findings can include incomplete AI system inventories, weak governance frameworks, insufficient training data documentation, inadequate model validation records, weak change control, incomplete data integrity controls, and insufficient human oversight of AI-generated outputs.

Q5: How does GxP Cellators support AI software compliance audits?

GxP Cellators supports organizations through full-scope AI software compliance audits, pre-audit readiness assessments, AI governance reviews, training data assessments, model validation documentation reviews, data integrity assessments, vendor audits, and mock inspection activities.

Q6: How do I contact GxP Cellators for AI software compliance audit support?

Organizations seeking support with AI software compliance audits can contact GxP Cellators to discuss their requirements, AI applications, audit scope, and compliance objectives.

Contact GxP Cellators

If your organization uses AI applications within pharmaceutical or other GxP-regulated activities and requires compliance assessment, GxP Cellators can provide specialized audit support.

Contact GxP Cellators: /contact/

by Vinod

07/10/2026

Preparing for an AI application validation audit in a GxP environment requires proper planning, strong documentation, effective governance, and a clear understanding of audit expectations. AI-based applications have characteristics that can make their validation different from traditional computerized systems.

Auditors may review areas such as AI model development, training data, intended use, risk management, human oversight, change control, and system performance. Therefore, organizations should begin their preparation well before the actual audit.

This guide explains how to prepare for an AI application validation audit and how GxP Cellators can support organizations with AI audit preparation and readiness activities.

Step 1: Understand Your AI Systems

The first step in preparing for an AI validation audit is to establish a clear understanding of all AI applications used within your organization.

You should:

Create or update an inventory of AI systems.
Define the intended use of every AI application.
Identify the GxP processes and activities supported by each system.
Determine the risk level associated with every AI application.
Document the type of AI or machine learning model being used.
Record information about how the model was developed and trained.
Explain how the AI system generates and delivers outputs.
Document human review and oversight mechanisms.

Having this information clearly documented allows your organization to demonstrate control over its AI applications during an audit.

Step 2: Review and Update Your Documentation

Documentation is one of the most important areas auditors examine. Before the audit, review all relevant records to ensure they are complete, accurate, current, and consistent with actual system practices.

Important documents may include:

System Requirements Specifications
AI validation plans and reports
Model development documentation
Training data documentation
AI risk assessments
Standard Operating Procedures
User manuals and training records
Change control documentation
Audit trail records
User access and security records

Any missing, outdated, or inconsistent documentation should be identified and corrected before the audit.

Step 3: Evaluate Your AI Governance Framework

Effective AI governance helps organizations maintain control over AI applications throughout their lifecycle. During audit preparation, review whether your governance framework clearly defines how AI systems are managed, monitored, changed, and approved.

Consider the following questions:

Is there a documented AI governance framework?
Are roles and responsibilities clearly assigned?
Is there an AI oversight committee or equivalent governance structure?
Are AI applications covered by appropriate GxP change control procedures?
Is there a formal process for reviewing and approving AI model updates?
Are AI-related risks included in the organization’s quality risk management process?
Are responsibilities for monitoring AI performance clearly defined?

Strong governance demonstrates that AI is being managed as a controlled GxP system rather than simply as a technology tool.

Step 4: Prepare Your Team

An AI validation audit does not only evaluate systems and documentation. Auditors may also interview personnel responsible for developing, validating, operating, or overseeing AI applications.

Prepare your team by:

Training employees on AI validation requirements.
Ensuring personnel understand their responsibilities for AI oversight.
Preparing employees for potential auditor interviews.
Conducting internal mock audits.
Practicing explanations of AI model development and validation.
Ensuring employees understand relevant procedures and controls.

Mock interviews can help identify knowledge gaps and improve the team’s confidence before the actual audit.

Step 5: Conduct a Pre-Audit Gap Assessment

A pre-audit gap assessment can help identify weaknesses before they become audit findings. It provides an opportunity to compare your existing AI systems, documentation, governance, and controls against applicable audit expectations.

During the assessment, you should:

Review AI systems against an appropriate audit checklist.
Identify gaps in documentation and validation.
Evaluate AI governance and oversight controls.
Review risk management processes.
Identify weaknesses in access controls, audit trails, or change control.
Develop corrective and preventive action plans.
Complete necessary corrections before the audit.

Addressing identified gaps early can significantly improve AI validation readiness.

How GxP Cellators Helps You Prepare for an AI Validation Audit

GxP Cellators provides AI audit preparation and validation support for organizations operating in regulated GxP environments. Our team can help identify compliance gaps, review documentation, assess governance practices, and prepare personnel for potential audit questions.

Our AI Audit Preparation Services Include:

Pre-audit gap assessments for AI applications
AI governance framework reviews
Documentation reviews and gap analysis
Mock AI validation audits
Training on AI validation and audit expectations
CAPA plan development and implementation support

These services are designed to provide practical recommendations that organizations can implement before an audit or inspection.

Why Choose GxP Cellators?

GxP Cellators supports organizations with a risk-based approach to AI validation and GxP compliance.

Key advantages include:

Professionals with experience in GxP and AI technologies
Consideration of FDA, EMA, Health Canada, MHRA, and WHO expectations
Risk-based assessment tailored to individual AI applications
Practical and actionable audit preparation recommendations
Confidential handling of proprietary AI systems and information

This approach helps organizations identify potential weaknesses and improve their overall AI audit readiness.

Frequently Asked Questions

Q1: How far in advance should I prepare for an AI validation audit?

AI audit preparation should begin as early as possible, preferably several months before a planned audit or inspection. Starting early provides sufficient time to identify gaps, update documentation, strengthen controls, and implement corrective actions.

Q2: What documents should I have ready for an AI validation audit?

Important documents may include the AI system inventory, intended-use documentation, risk assessments, validation plans and reports, model development records, training data documentation, SOPs, training records, and change control documentation.

Q3: How can I prepare my team for an AI validation audit?

Train employees on AI validation requirements and their specific responsibilities. You can also conduct mock audits, prepare employees for auditor interviews, and practice explaining AI model development, validation, monitoring, and oversight processes.

Q4: What is a pre-audit gap assessment?

A pre-audit gap assessment evaluates AI systems, documentation, governance, and controls against applicable audit requirements. It helps identify weaknesses early so corrective actions can be completed before the actual audit.

Q5: How does GxP Cellators help with AI audit preparation?

GxP Cellators supports AI audit preparation through pre-audit gap assessments, AI governance reviews, documentation assessments, mock audits, validation training, and CAPA development support.

Q6: How do I contact GxP Cellators for AI audit preparation support?

You can contact GxP Cellators through the official contact page to discuss your AI validation audit preparation requirements and understand how the team can support your organization.

Contact GxP Cellators

If your organization needs professional support to prepare for an AI application validation audit in a GxP environment, GxP Cellators can help with audit readiness, gap assessment, documentation review, governance evaluation, and validation preparation.

Contact GxP Cellators: /contact/

by Vinod

07/10/2026

Computer System Validation (CSV) has been an important part of GxP compliance for many years. Traditional CSV follows a structured approach that includes defining requirements, designing the system, testing it against approved requirements, documenting results, and maintaining the validated state throughout the system lifecycle.

However, artificial intelligence systems introduce new challenges that do not always fit into the traditional CSV model. AI applications may change their behavior based on training data, model updates, or ongoing learning.

This makes AI validation vs traditional CSV an important consideration for organizations using AI in regulated GxP environments. GxP auditors need to understand these differences when assessing AI applications.

GxP Cellators supports organizations with both traditional CSV audits and AI validation audits, helping them identify compliance risks and strengthen their validation controls.

Key Differences Between AI Validation and Traditional CSV

1. Determinism

Traditional computerized systems are generally deterministic. When the same input is provided under the same conditions, the system is expected to produce the same output. This makes it easier for auditors to verify system behavior through predefined validation tests.

AI systems can behave differently. Depending on the model, training data, configuration, or context, the same input may sometimes produce different results.

Therefore, AI validation needs to consider variability and may require additional testing methods to evaluate model performance.

2. Learning and Adaptation

Traditional systems normally do not change their behavior unless an authorized system change is implemented through a formal change control process.

Some AI applications, however, may learn from new information or be updated regularly. This can potentially affect their behavior over time.

GxP organizations therefore need controls that identify when an AI model changes and determine whether additional validation is required.

3. Transparency

Traditional software is generally easier to trace. Requirements can be linked to system design, functionality, code, and testing activities.

Many AI models can be more difficult to interpret. The reasoning behind a particular output may not always be easy to explain.

For this reason, AI validation documentation should address model transparency and explainability where applicable, particularly when AI outputs can affect GxP processes or decisions.

4. Data Dependency

Traditional computerized systems rely on data inputs, but their core logic is primarily defined through programmed rules and code.

AI systems can be highly dependent on training data. The quality, completeness, accuracy, and representativeness of that data can directly influence model behavior.

AI validation therefore needs to consider training data quality, data governance, data integrity, and the suitability of datasets used during model development.

5. Performance Monitoring

Traditional systems are commonly monitored for errors, failures, incidents, and deviations.

AI systems require an additional focus on ongoing performance. Model accuracy or effectiveness can change over time because of changing data, environments, or operational conditions.

Continuous or periodic monitoring should therefore be considered as part of the AI validation lifecycle.

Validation Approach Comparison

Aspect	Traditional CSV	AI Validation
Determinism	Generally deterministic outputs	Non-deterministic outputs may occur
Learning	No learning after release unless changed	Some systems may learn or adapt
Transparency	Generally easier to understand	Models may be difficult to interpret
Data Dependency	Logic mainly defined by code	Behavior strongly influenced by training data
Performance Monitoring	Focus on failures and deviations	Requires ongoing model performance monitoring
Change Control	Formal change control process	May require continuous or enhanced monitoring
Documentation	Requirements, design, testing, and results	Model development, training data, testing, and validation
Human Oversight	User training and operational procedures	Human review and intervention may be required

What GxP Auditors Should Check

When auditing AI applications, GxP auditors should look beyond the areas traditionally reviewed during CSV audits.

Important areas may include:

AI system inventory and risk assessment
AI governance and management oversight
Training data quality and governance
Model development and validation documentation
Model version control
AI model change management
Human oversight and intervention procedures
Data integrity controls
AI-specific cybersecurity controls
Regulatory and GxP compliance
Vendor and supplier controls for AI applications
Ongoing AI performance monitoring
Documentation of model testing and validation decisions

These controls help organizations demonstrate that AI applications remain suitable for their intended GxP use.

How GxP Cellators Supports CSV and AI Validation Audits

GxP Cellators provides auditing support for both traditional computerized systems and emerging AI technologies used in regulated environments.

Our auditors understand that AI applications can introduce validation challenges that are different from conventional software. We help organizations assess these risks and determine whether appropriate controls, documentation, testing, and oversight are in place.

Our CSV and AI Audit Services Include:

Traditional CSV audits for GxP computerized systems
AI application validation audits
CSV support for emerging technologies
21 CFR Part 11 compliance audits
EU GMP Annex 11 compliance audits
Data integrity audits
Vendor and supplier audits
Mock inspections for CSV and AI systems

Why Choose GxP Cellators?

GxP Cellators supports organizations with a practical and risk-based approach to computerized system and AI auditing.

Key advantages include:

Experienced auditors familiar with CSV and AI technologies
Coverage of FDA, EMA, Health Canada, MHRA, and WHO expectations
Risk-based audit approaches tailored to individual systems
Practical and actionable audit reports
Confidential handling of proprietary information
Support for both traditional computerized systems and emerging AI applications

Frequently Asked Questions

Q1: Can traditional CSV methods be applied to AI systems?

Traditional CSV principles can provide a foundation for AI validation, but they may not be sufficient on their own. AI systems can require additional controls and validation activities to address factors such as non-deterministic behavior, model changes, data dependency, explainability, and ongoing performance.

Q2: What is the biggest difference between CSV and AI validation?

One of the major differences is determinism. Traditional computerized systems are generally expected to produce consistent results when the same input and conditions are used. AI systems may produce different outputs depending on model configuration, data, and context. This can require additional testing and performance monitoring.

Q3: Do AI systems need to comply with 21 CFR Part 11?

When AI systems are used in GxP environments and create, modify, maintain, or use electronic records or electronic signatures within the scope of the regulation, applicable 21 CFR Part 11 controls need to be considered. Relevant computerized system requirements, including EU GMP Annex 11 where applicable, should also be assessed.

Q4: How does GxP Cellators support CSV and AI validation?

GxP Cellators provides auditing services for traditional CSV systems as well as AI applications. Its auditors assess system risks, validation controls, data integrity, governance, documentation, and other relevant compliance areas to help organizations identify gaps and strengthen their controls.

Q5: How can I contact GxP Cellators for CSV or AI validation support?

Organizations looking for CSV or AI validation audit support can contact GxP Cellators through its contact page to discuss their requirements and compliance needs.

Contact GxP Cellators

If your organization needs support with CSV audits, AI validation audits, data integrity, or GxP computerized system compliance, GxP Cellators can help assess your requirements and identify potential compliance gaps.

Contact GxP Cellators: /contact/

by Vinod

06/10/2026

Artificial intelligence brings tremendous potential to pharmaceutical operations, but it also introduces compliance risks that traditional validation approaches were not designed to address. When AI systems are used in GxP environments, the risks to data integrity, product quality, and patient safety must be identified, assessed, and controlled. This blog examines the key compliance risks that AI application validation audits must address and explains how GxP Cellators helps pharmaceutical companies manage these risks.

Risk 1: Non Deterministic Behavior

Traditional computer systems produce the same output for the same input every time. AI systems do not. Machine learning models can produce different outputs for the same input depending on training data, model updates, or contextual factors. This non deterministic behavior creates significant validation challenges.

Audit Considerations:

How do you validate a system that may produce different outputs
How do you define acceptance criteria for non deterministic systems
How do you monitor ongoing performance
How do you detect when model behavior changes

Risk 2: Data Integrity in Training and Operation

AI models depend on data. The quality of training data directly affects model performance. Data integrity issues in training data can lead to biased, inaccurate, or unreliable outputs. Data integrity issues during operation can corrupt model inputs and lead to incorrect outputs.

Audit Considerations:

Is training data sourced from reliable sources
Is training data representative of the intended use population
Are data preprocessing steps documented and controlled
Are audit trails enabled for model inputs and outputs
Are access controls in place to prevent unauthorized changes

Risk 3: Model Governance and Change Control

AI models can be updated frequently. Some systems learn continuously from new data. Traditional change control processes may not be sufficient to manage AI model changes.

Audit Considerations:

Is there a defined process for reviewing and approving model updates
Are model changes subject to change control
Is there a process for revalidating models after updates
Is model version history documented
Is there a process for rolling back problematic updates

Risk 4: Lack of Transparency and Explainability

Many AI models, particularly deep learning models, are black boxes. Understanding why a model produced a specific output can be difficult or impossible. This lack of transparency creates challenges for validation, auditing, and regulatory acceptance.

Audit Considerations:

Is the model architecture documented
Are model assumptions and limitations documented
Is there a process for explaining model outputs
Are human reviewers able to understand and challenge AI outputs
Is there documentation of model development and validation

Risk 5: Human Oversight and Accountability

AI in GxP environments should augment human decision making, not replace it entirely. Without appropriate human oversight, AI errors can go undetected and uncorrected.

Audit Considerations:

Is there a defined process for human review of AI outputs
Are humans able to override or reject AI recommendations
Is there documentation of human interventions
Are personnel trained on the limitations of AI systems
Are decisions made based on AI outputs documented and justified

Risk 6: Vendor and Supplier Management

Many AI applications are provided by external vendors. Vendor management introduces risks related to transparency, quality, and continuity.

Audit Considerations:

Has the AI vendor been qualified
Is there a quality agreement with the AI vendor
Does the vendor provide documentation sufficient for validation
Does the vendor notify you of model updates
Is there a process for auditing the AI vendor
Is there a contingency plan if the vendor discontinues the service

Risk 7: Regulatory Uncertainty

Regulations for AI in GxP are still evolving. Regulatory expectations may change over time. Organizations must monitor regulatory developments and adapt their validation and audit approaches accordingly.

Audit Considerations:

Are regulatory expectations for AI in GxP being monitored
Is there a process for updating compliance as regulations evolve
Is the AI system compliant with current 21 CFR Part 11 requirements
Is the AI system compliant with current EU GMP Annex 11 requirements
Are data integrity requirements being met

How GxP Cellators Helps Manage AI Compliance Risks

GxP Cellators provides specialized AI auditing services that help pharmaceutical companies identify, assess, and mitigate AI compliance risks. Our auditors understand both the regulatory requirements and the technical characteristics of AI systems.

Our AI Risk Management Services Include:

AI compliance risk assessments
AI governance framework audits
Training data quality and integrity audits
AI model validation documentation reviews
Human oversight process audits
AI vendor and supplier audits
Regulatory compliance reviews
Mock AI audits to prepare for inspections

Why Choose GxP Cellators for AI Risk Management:

Auditors with deep experience in GxP and AI technologies
Coverage of FDA, EMA, Health Canada, MHRA, and WHO requirements
Risk based approach tailored to your AI applications
Practical recommendations for risk mitigation
Full confidentiality for your proprietary systems

Frequently Asked Questions

Q1: What are the biggest compliance risks for AI in pharma?

The biggest risks include non deterministic behavior, data integrity issues in training and operation, inadequate model governance, lack of transparency, insufficient human oversight, vendor management gaps, and regulatory uncertainty.

Q2: How can AI compliance risks be mitigated?

Risks can be mitigated through a structured AI governance framework, rigorous training data quality controls, comprehensive model documentation, defined human oversight processes, vendor qualification and auditing, and ongoing regulatory monitoring.

Q3: What role does data integrity play in AI compliance?

Data integrity is fundamental to AI compliance. Training data must be accurate, complete, and representative. Operational data must be protected from unauthorized changes. Audit trails must be enabled for model inputs and outputs.

Q4: How does GxP Cellators help with AI compliance risk management?

GxP Cellators provides AI compliance risk assessments, governance framework audits, training data quality audits, model validation reviews, human oversight audits, and vendor audits. We help you identify and mitigate AI compliance risks.

Q5: How do I contact GxP Cellators for AI risk management support?

You can reach us through our contact page at /contact/ to discuss your AI validation audit requirements.

Contact GxP Cellators

If you need support with AI application validation audits and compliance risk management, please contact GxP Cellators.

Contact: /contact/

by Vinod

06/10/2026

Auditing an AI application under GxP requirements requires a different mindset than auditing a traditional computerized system. The auditor must understand not only the regulatory expectations but also the technical characteristics that make AI systems unique. This blog provides a practical guide to planning, executing, and reporting AI application audits in GxP environments. It also explains how GxP Cellators can support your organization through every phase of the audit process.

Phase 1: Audit Planning and Preparation

Understanding the AI Application

Before the audit begins, the auditor must understand the AI application being audited.

What is the intended use of the AI application
What GxP activities does it support
What is the risk level of the application
What type of AI or machine learning model is used
How was the model developed and trained
How does the model produce outputs
What human oversight exists

Reviewing Documentation

The auditor should review available documentation before the audit.

System requirements specification
Validation plan and report
Model development documentation
Training data documentation
Risk assessment
Standard operating procedures
User manuals and training materials

Defining Audit Scope and Criteria

The audit scope should clearly define what will be examined and against what criteria.

Which AI systems or models will be audited
Which GxP regulations and standards apply
What processes and documentation will be reviewed
What personnel will be interviewed
What testing or verification will be performed

Phase 2: Audit Execution

Opening Meeting

The audit begins with an opening meeting to confirm scope, objectives, and logistics.

Introduce the audit team
Confirm the audit scope and criteria
Explain the audit process and timeline
Confirm confidentiality arrangements
Schedule interviews and document reviews

Document Review

The auditor reviews documentation to verify compliance.

Is the validation documentation complete and approved
Is the risk assessment documented and appropriate
Is the training data documentation sufficient
Is the model development documentation complete
Are standard operating procedures current and followed

Interviews

Interviews with key personnel provide insight into actual practices.

System owners and administrators
Quality assurance personnel
End users of the AI application
IT and data management personnel
Vendor representatives if applicable

System Walkthrough

The auditor examines the AI system in operation.

How is the system accessed and used
What controls are in place for data input
How are outputs generated and reviewed
What audit trails exist
How are model updates managed

Testing and Verification

The auditor may perform testing to verify controls.

Verify that audit trails capture required information
Verify that access controls are effective
Verify that outputs are attributable to the system
Verify that human oversight is documented
Verify that model version control is effective

Phase 3: Findings and Classification

Identifying Findings

Findings are identified when practices or documentation do not meet audit criteria.

Critical findings: direct impact on patient safety or data integrity
Major findings: significant deviation from requirements
Minor findings: isolated or low impact issues
Observations: opportunities for improvement

Classifying Findings

Each finding should be classified based on risk and impact.

Classification	Definition	Response Required
Critical	Direct impact on patient safety or data integrity	Immediate action required
Major	Significant deviation from requirements	Corrective action required
Minor	Isolated or low impact issue	Correction recommended
Observation	Opportunity for improvement	Consideration recommended

Phase 4: Reporting and Follow Up

Audit Report

The audit report documents findings and recommendations.

Executive summary
Audit scope and criteria
Methodology
Findings with classification
Root cause analysis where applicable
Corrective and preventive action recommendations
Attachments and evidence

Close Out Meeting

The close out meeting presents findings to the auditee.

Present findings and classifications
Discuss root causes and corrective actions
Confirm timelines for CAPA
Document agreements and disagreements

CAPA Follow Up

The auditor verifies that corrective and preventive actions are implemented.

Review CAPA plans
Verify implementation
Assess effectiveness
Close findings when appropriate

How GxP Cellators Supports AI Application Audits

GxP Cellators provides comprehensive AI application audit services for GxP organizations. Our auditors have experience with both traditional CSV and emerging AI technologies. We help you navigate the unique challenges of auditing AI systems and demonstrate compliance to regulators.

Our AI Audit Services Include:

Full scope AI application audits from planning through reporting
Pre audit readiness assessments for AI systems
Mock AI audits to prepare your team for regulatory inspection
AI governance framework assessments
Data integrity audits for AI systems
AI model validation documentation reviews
Vendor and supplier audits for AI applications
CAPA verification and follow up audits
Training on AI auditing best practices

Why Choose GxP Cellators for AI Audits:

Auditors with deep experience in both GxP and AI technologies
Coverage of FDA, EMA, Health Canada, MHRA, and WHO requirements
Risk based audit approach tailored to your AI applications
Clear, actionable reports that support remediation
Full confidentiality for your proprietary systems

Frequently Asked Questions

Q1: What is the first step in auditing an AI application under GxP?
The first step is understanding the AI application. You must know its intended use, the GxP activities it supports, the type of model used, how it was developed and trained, and what human oversight exists. This understanding forms the basis for the audit plan.

Q2: How long does an AI application audit take?
The duration depends on the complexity of the AI application, the scope of the audit, and the availability of documentation. A focused audit of a single AI application may take several days. A comprehensive audit of multiple AI systems across an organization may take several weeks.

Q3: What qualifications should an AI auditor have?
An AI auditor should have experience with GxP regulations including 21 CFR Part 11 and EU GMP Annex 11. They should understand computer system validation principles. They should also have knowledge of AI and machine learning technologies, including model development, training data, and performance monitoring.

Q4: What are common findings in AI application audits?
Common findings include incomplete AI system inventories, lack of AI governance frameworks, inadequate training data documentation, insufficient model validation documentation, and inadequate human oversight processes.

Q5: How does GxP Cellators support AI application audits?
GxP Cellators provides full scope AI application audits, pre audit readiness assessments, mock audits, governance reviews, data integrity audits, and vendor audits. We help you identify gaps and prepare for regulatory inspections.

Q6: How do I contact GxP Cellators for AI audit support?
You can reach us through our contact page at /contact/ to discuss your AI audit requirements.

Contact GxP Cellators

If you need support with AI application audits under GxP requirements, please contact GxP Cellators.

Contact: /contact/

by Vinod

06/10/2026

Artificial intelligence is no longer a future concept in pharmaceutical operations. It is here today, embedded in manufacturing analytics, clinical data review, pharmacovigilance signal detection, and quality management systems. With this rapid adoption comes a critical question that every quality leader must answer. How do you validate an AI application in a GxP environment?

Traditional computer system validation was built for deterministic systems. You define requirements, you test against those requirements, and you verify that the system does what it is supposed to do every single time. AI systems do not work that way. They learn. They adapt. Their outputs can change based on new data. This fundamental difference creates unique validation challenges that regulators are still working to address.

This blog provides a comprehensive audit checklist for AI application validation in GxP environments. It covers what auditors should examine, what evidence you need, and how to demonstrate compliance when the technology itself is non deterministic. It also explains how GxP Cellators supports pharmaceutical companies through every phase of the AI validation audit process.

Why AI Validation Is Different from Traditional CSV

Traditional CSV follows a linear lifecycle. User requirements are defined. Design specifications are created. The system is built or configured. Testing verifies that the system meets requirements. The system is released and maintained in a validated state.

AI validation must account for characteristics that traditional CSV does not address.

Non deterministic outputs. An AI model may produce different outputs for the same input depending on training data, model updates, or contextual factors. This means that traditional pass or fail testing may not be sufficient. Validation must include statistical approaches and ongoing monitoring.
Continuous learning. Some AI systems update their models based on new data, which means the validated state can change without a formal change control trigger. Organizations must define what constitutes a significant model change and establish processes for reviewing and approving updates.
Opacity. Many AI models, particularly deep learning models, are black boxes. Understanding why a model produced a specific output can be difficult or impossible. Validation documentation must address model explainability to the extent possible and define human oversight requirements.
Data dependency. AI model performance depends heavily on the quality, completeness, and representativeness of training data. Validation must include assessment of training data quality and governance.
Evolving performance. Model performance can degrade over time as real world conditions diverge from training conditions. Ongoing performance monitoring is essential for maintaining the validated state.

The GxP AI Validation Audit Checklist

Section 1: AI System Inventory and Risk Assessment

Before validating any AI application, you must know what AI systems you have and how much risk each one carries. A complete inventory is the foundation of any validation program.

Have you identified all AI and machine learning applications used in GxP activities
Is each AI application documented in your system inventory
Has each AI application been risk assessed for its impact on product quality and patient safety
Is the risk assessment documented and approved
Has the risk assessment considered the specific characteristics of AI systems
Are high risk AI applications subject to more stringent validation requirements
Is the inventory reviewed and updated on a regular basis
Are new AI applications added to the inventory before deployment

Section 2: AI Governance and Oversight

AI governance ensures that AI systems are developed, deployed, and maintained responsibly. Without governance, AI systems can proliferate without appropriate oversight.

Is there a documented AI governance framework
Are roles and responsibilities for AI systems clearly defined
Is there an AI oversight committee or equivalent governance body
Are AI systems subject to the same change control processes as other GxP systems
Is there a process for reviewing and approving AI model updates
Are AI related risks included in the quality risk management system
Is there a process for retiring or decommissioning AI systems
Are governance decisions documented and communicated

Section 3: Training Data Quality and Governance

AI model performance depends on the data used to train and validate it. Poor quality training data leads to poor quality outputs.

Is training data sourced from reliable and qualified sources
Is training data representative of the intended use population
Has training data been assessed for completeness and accuracy
Is there documentation of data preprocessing and feature engineering
Has training data been reviewed for bias and fairness
Is there a process for managing training data updates
Are data provenance and lineage documented
Is training data protected from unauthorized modification

Section 4: AI Model Development and Validation

The model itself must be developed and validated using a documented, risk based approach.

Is there a documented model development methodology
Are model requirements defined and traceable
Has the model been validated against predefined acceptance criteria
Are performance metrics appropriate for the intended use
Has the model been tested with independent validation data
Is there documentation of model limitations and assumptions
Has the model been reviewed and approved by qualified personnel
Is there a process for ongoing model performance monitoring

Section 5: AI Model Documentation

Documentation is essential for regulatory acceptance and ongoing maintenance.

Is the intended use of the AI application clearly documented
Is the model architecture documented
Are model inputs and outputs clearly defined
Are model assumptions and limitations documented
Is the training data documented
Are validation results documented
Is there documentation of model version history
Is there a process for updating documentation when models change

Section 6: Human Oversight and Intervention

AI in GxP environments should augment human decision making, not replace it entirely. Human oversight ensures that AI errors are detected and corrected.

Is there a defined process for human review of AI outputs
Are humans able to override or reject AI recommendations
Is there documentation of human interventions
Are personnel trained on the limitations of AI systems
Is there a process for escalating AI related concerns
Are decisions made based on AI outputs documented and justified
Is there a process for monitoring the effectiveness of human oversight

Section 7: Data Integrity for AI Systems

Data integrity principles apply to AI systems just as they do to any GxP system.

Are audit trails enabled for AI system inputs and outputs
Are access controls in place to prevent unauthorized changes
Are AI model changes documented and approved
Is there a process for detecting and investigating data integrity issues
Are AI outputs attributable to the system and any human reviewers
Is data associated with AI systems legible, contemporaneous, original, and accurate
Are data backups performed and tested
Is data protected from loss or corruption

Section 8: AI System Security

AI systems can be vulnerable to unique security threats.

Is the AI system protected from unauthorized access
Is there protection against adversarial inputs
Is there protection against data poisoning
Is there protection against model theft
Are security incidents documented and investigated
Is there a process for responding to AI specific security incidents
Are security controls tested and updated regularly

Section 9: Regulatory Compliance

AI systems in GxP must comply with applicable regulations.

Does the AI system comply with 21 CFR Part 11 for electronic records and signatures
Does the AI system comply with EU GMP Annex 11 for computerized systems
Is the AI system compliant with data integrity requirements
Are regulatory expectations for AI in GxP being monitored
Is there a process for updating compliance as regulations evolve
Are regulatory submissions involving AI systems supported by appropriate documentation

Section 10: Vendor and Supplier Management

Many AI applications are provided by external vendors.

Has the AI vendor been qualified
Is there a quality agreement with the AI vendor
Does the vendor provide documentation sufficient for validation
Does the vendor notify you of model updates
Is there a process for auditing the AI vendor
Is there a contingency plan if the vendor discontinues the service
Are vendor performance and compliance monitored on an ongoing basis

How GxP Cellators Supports AI Application Validation Audits

GxP Cellators provides specialized AI application validation audits for pharmaceutical, biotechnology, and medical device companies. Our auditors understand both the regulatory requirements and the technical characteristics of AI systems. We help you build confidence in your AI applications and demonstrate compliance to regulators.

Our AI Validation Audit Services Include:

AI system inventory and risk assessment reviews
AI governance framework assessments
Training data quality audits
AI model validation documentation reviews
Human oversight process audits
Data integrity audits for AI systems
AI security assessments
Regulatory compliance reviews for 21 CFR Part 11 and Annex 11
Vendor and supplier audits for AI applications
CSV AI support for emerging technologies
Mock AI audits to prepare for regulatory inspection
CAPA verification and follow up audits

Why Choose GxP Cellators for AI Validation Audits:

Auditors with both CSV and AI technology experience
Coverage of FDA, EMA, Health Canada, MHRA, and WHO requirements
Risk based approach tailored to your AI applications
Practical, actionable reports that support remediation
Full confidentiality for your proprietary AI systems
Global reach with regional expertise

Conclusion

AI application validation is one of the most complex challenges facing GxP organizations today. The technology is evolving faster than the regulations, and auditors must navigate uncertainty while maintaining compliance. A structured, risk based approach to AI validation auditing helps you identify gaps, address risks, and demonstrate that your AI systems are fit for purpose.

Frequently Asked Questions

Q1: What is AI application validation in GxP?
AI application validation in GxP is the process of demonstrating that an artificial intelligence system used in regulated activities is fit for its intended purpose. It includes documenting the intended use, validating model performance, ensuring data integrity, establishing human oversight, and maintaining the validated state over time.

Q2: How is AI validation different from traditional CSV?
AI validation differs from traditional CSV in several ways. AI systems may be non deterministic, meaning the same input can produce different outputs. They may learn continuously from new data. They are often less transparent than traditional systems. And their performance can degrade over time. These characteristics require validation approaches that go beyond traditional requirements based testing.

Q3: What regulations apply to AI applications in GxP?
The primary regulations are 21 CFR Part 11 for electronic records and signatures, EU GMP Annex 11 for computerized systems, and data integrity requirements based on ALCOA+ principles. GAMP 5 provides a risk based framework for validation. Regulatory guidance for AI in GxP is still evolving.

Q4: How often should AI applications be revalidated?
Revalidation triggers should be defined based on risk. Triggers may include significant model updates, changes in training data, changes in intended use, performance degradation, or regulatory changes. Ongoing performance monitoring helps identify when revalidation is needed.

Q5: What documentation is required for AI validation?
Required documentation includes system requirements, model development methodology, training data documentation, validation plan and report, risk assessment, standard operating procedures, human oversight procedures, and change control records.

Q6: How does GxP Cellators help with AI validation audits?
GxP Cellators provides comprehensive AI validation audit services including pre audit assessments, governance reviews, training data audits, model validation documentation reviews, data integrity audits, and mock inspections. We help you identify gaps and prepare for regulatory scrutiny.

Q7: How do I contact GxP Cellators for AI validation audit support?

You can reach us through our contact page at https://www.gxpcellators.com/contact/ to discuss your AI validation audit requirements.

Contact GxP Cellators

If you need support with AI application validation audits in your GxP environment, please contact GxP Cellators. Our team of experts is ready to help you navigate the unique challenges of AI compliance.

Contact: https://www.gxpcellators.com/contact/

by Vinod

15/08/2026

The Path to Audit Success

A successful GLP audit does not happen by accident. It is the result of careful planning, thorough preparation, and a genuine commitment to GLP principles. Organizations that consistently pass GLP audits with few or no findings invest significant effort in audit preparation.

Preparing for a GLP audit can seem daunting, especially given the breadth of GLP requirements. However, by taking a systematic approach and focusing on the areas that regulators care about most, you can transform audit preparation from a stressful scramble into a manageable process.

This article provides a comprehensive guide to preparing your research laboratory for a successful GLP audit. Whether you are preparing for your first GLP audit or seeking to improve your compliance posture, these strategies will help you achieve audit success.

Understanding What Regulators Look For

Before you can prepare for a GLP audit, you must understand what regulators will be looking for. GLP inspectors evaluate compliance across multiple areas, including:

Organization and Personnel
Regulators verify that your laboratory has qualified personnel with clearly defined responsibilities. They check training records and ensure that Study Directors are properly designated.

Quality Assurance Unit
Regulators evaluate the independence and effectiveness of your QAU. They review QAU inspection records and ensure that the QAU has performed protocol and final report reviews.

Facilities and Equipment
Regulators inspect your facilities to ensure they are adequate and well-maintained. They review equipment calibration and maintenance records.

Test and Reference Items
Regulators verify that test and reference items are properly characterized, stored, and handled.

Standard Operating Procedures
Regulators review your SOPs to ensure they are comprehensive, current, and available to personnel.

Study Performance
Regulators evaluate how studies are conducted, from protocol approval to data recording. They ensure that deviations are documented and justified.

Data Integrity
Regulators scrutinize data for accuracy, completeness, and traceability. They review audit trails for electronic records.

Archives
Regulators inspect archives to ensure that study records and samples are securely stored and accessible.

Phase 1: Pre-Audit Preparation

Pre-audit preparation is the foundation of audit success. This phase involves assessing your current compliance posture, identifying gaps, and taking corrective action.

Conduct a Self-Audit
The first step in pre-audit preparation is to conduct a thorough self-audit. This involves reviewing your GLP systems against regulatory requirements and identifying areas of non-compliance. A self-audit can be conducted by your internal QAU or by external consultants.

Identify Gaps
Based on your self-audit, identify gaps in your GLP systems. These may include missing documentation, inadequate training, or deficient facilities. Prioritize gaps based on their severity and the likelihood of regulatory finding.

Develop a CAPA Plan
For each identified gap, develop a corrective and preventive action plan. The CAPA plan should include specific actions, responsible parties, timelines, and verification procedures.

Implement Corrective Actions
Implement the corrective actions identified in your CAPA plan. This may involve updating SOPs, providing additional training, or repairing equipment.

Verify Effectiveness
Once corrective actions are implemented, verify that they are effective. This may involve additional self-audits or monitoring of key performance indicators.

Phase 2: Audit Preparation Activities

With your compliance gaps addressed, you can move to more specific audit preparation activities.

Organize Your Documentation
Regulators will request documentation during the audit. Organize your documentation in advance to ensure you can provide it quickly. This includes study plans, raw data, final reports, SOPs, training records, and equipment records.

Prepare Your Facilities
Ensure that your facilities are clean, organized, and in good repair. Remove clutter and ensure that work areas are tidy. Check that signage is clear and that safety equipment is visible.

Prepare Your Personnel
Ensure that all personnel are aware that an audit is scheduled and understand their roles during the audit. Provide training on audit procedures, including how to respond to inspector questions.

Conduct Mock Audits
Mock audits are one of the most effective ways to prepare for a GLP audit. During a mock audit, an internal or external auditor conducts a simulated inspection, identifying areas for improvement and providing practice in responding to inspector questions.

Review Previous Audit Findings
If you have undergone previous GLP audits, review the findings and ensure that corrective actions are complete and effective. Regulators expect that previous findings have been addressed.

Phase 3: During the Audit

During the audit, your focus should be on cooperating with the inspector and providing complete and accurate information.

Designate an Audit Host
Designate an individual to serve as the host for the inspector. This person should be knowledgeable about your GLP systems and able to answer questions and facilitate access to personnel and records.

Respond to Inspector Questions Honestly
When the inspector asks questions, respond honestly and accurately. If you do not know the answer, say so and offer to find out. Do not speculate or provide inaccurate information.

Provide Documentation Promptly
When the inspector requests documentation, provide it promptly. If documentation is not immediately available, explain why and provide an estimated time when it will be available.

Take Notes
Take notes during the audit, especially of any observations or concerns expressed by the inspector. This will help you address findings after the audit.

Remain Professional
Throughout the audit, remain professional and courteous. Do not become defensive or argumentative, even if you disagree with the inspector’s observations.

Phase 4: Post-Audit Activities

After the audit, your focus should shift to addressing any findings and preparing for future audits.

Review Audit Findings
When you receive the audit report, review the findings carefully. Identify any areas of non-compliance and determine the root causes.

Develop CAPA Plans
For each finding, develop a CAPA plan. The plan should include specific actions, responsible parties, timelines, and verification procedures.

Implement CAPA Actions
Implement the CAPA actions identified in your plan. This may involve updating SOPs, providing additional training, or making facility improvements.

Verify Effectiveness
Once CAPA actions are implemented, verify that they are effective. This may involve additional self-audits or monitoring of key performance indicators.

Document CAPA Activities
Document all CAPA activities, including the original finding, the corrective action taken, and the verification of effectiveness. This documentation should be retained for future reference.

Learn from the Experience
Reflect on the audit experience and identify lessons learned. Consider how you can improve your compliance systems and audit preparation processes for future audits.

How GxP Cellators Can Help You Prepare for a GLP Audit

At GxP Cellators, we understand the challenges of preparing for a GLP audit. With over 500 GLP audits successfully completed, our certified GLP and IRCA auditors bring extensive experience in helping laboratories achieve audit readiness.

Our team includes professionals with RQAP-GLP and IRCA Auditor certifications, ensuring that our auditing methodologies comply with international standards. We perform GLP audits on behalf of clients and sponsors, providing objective, third-party evaluations that carry greater credibility with regulatory authorities.

Our audit preparation services include:

Gap assessments: Comprehensive reviews of your GLP systems against OECD guidelines and 21 CFR Part 58, identifying compliance gaps and providing actionable recommendations
Mock audits: Simulated inspections that provide practice in responding to inspector questions and identifying areas for improvement
Readiness audits: Comprehensive assessments of your audit readiness, identifying areas that need attention before the actual audit
Documentation review: Thorough reviews of study plans, raw data, final reports, SOPs, training records, and other documentation
CAPA support: Assistance in developing and implementing CAPA plans for identified gaps
Full-spectrum GLP study audits: Including toxicology, pharmacokinetics, bioanalytical method validation, genotoxicity, reproductive toxicology, carcinogenicity, dermal and ocular toxicology, and ecotoxicology

Why sponsors choose us: We speak both the regulatory language and the scientific language. Our findings are factual, evidenced, and actionable. As an independent third-party audit firm, we have no organizational biases or conflicts of interest. Our audit reports carry greater credibility with regulatory authorities, clients, and business partners.

Our global presence spans Saskatchewan, Calgary, Toronto, North Carolina, Indiana, and Frankfurt, enabling us to deploy auditors worldwide and understand local regulatory nuances while upholding the OECD framework.

Ready to prepare your research laboratory for a successful GLP audit? Let GxP Cellators help you achieve GLP readiness with confidence.

Reach out to us today to schedule your GLP audit.

Email:

Phone: +1 (306) 715-9460

Website: /gxp-auditing/

GxP Cellators – Your Certified GLP Audit Partners

Older Posts